120 related articles for article (PubMed ID: 2830344)
1. A multivariate analysis of the risk of cytomegalovirus infection in heart transplant recipients.
Gorensek MJ; Stewart RW; Keys TF; McHenry MC; Goormastic M
J Infect Dis; 1988 Mar; 157(3):515-22. PubMed ID: 2830344
[TBL] [Abstract][Full Text] [Related]
2. A multivariate analysis of risk factors for cytomegalovirus infection in liver-transplant recipients.
Gorensek MJ; Carey WD; Vogt D; Goormastic M
Gastroenterology; 1990 May; 98(5 Pt 1):1326-32. PubMed ID: 1691121
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus as a risk factor in living-related renal transplantation. A prospective study.
Pollak R; Barber PL; Prusak BF; Mozes MF
Ann Surg; 1987 Mar; 205(3):302-4. PubMed ID: 3030201
[TBL] [Abstract][Full Text] [Related]
4. Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children.
Hussain T; Burch M; Fenton MJ; Whitmore PM; Rees P; Elliott M; Aurora P
Circulation; 2007 Apr; 115(13):1798-805. PubMed ID: 17353448
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus infections in heart and heart and lung transplant recipients.
Wreghitt TG; Hakim M; Gray JJ; Kucia S; Wallwork J; English TA
J Clin Pathol; 1988 Jun; 41(6):660-7. PubMed ID: 2838530
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing the occurrence of active cytomegalovirus (CMV) infections after organ transplantation.
Boland GJ; Hene RJ; Ververs C; de Haan MA; de Gast GC
Clin Exp Immunol; 1993 Nov; 94(2):306-12. PubMed ID: 8222321
[TBL] [Abstract][Full Text] [Related]
7. Does cytomegalovirus serology impact outcome after pediatric heart transplantation?
Mahle WT; Fourshee MT; Naftel DM; Alejos JC; Caldwell RL; Uzark K; Berg A; Kanter KR;
J Heart Lung Transplant; 2009 Dec; 28(12):1299-305. PubMed ID: 19783178
[TBL] [Abstract][Full Text] [Related]
8. Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients.
Mabilangan C; Preiksaitis JK; Cervera C;
Transpl Infect Dis; 2019 Feb; 21(1):e13015. PubMed ID: 30358023
[TBL] [Abstract][Full Text] [Related]
9. The influence of donor factors other than serologic status on transmission of cytomegalovirus to transplant recipients.
Chou SW; Norman DJ
Transplantation; 1988 Jul; 46(1):89-93. PubMed ID: 2839917
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants.
Marker SC; Howard RJ; Simmons RL; Kalis JM; Connelly DP; Najarian JS; Balfour HH
Surgery; 1981 Jun; 89(6):660-71. PubMed ID: 6264640
[TBL] [Abstract][Full Text] [Related]
11. [Importance of screening for antibodies to cytomegalovirus in organ transplantation].
Milbradt H; Flik J; Stangel W; Heigel R
Beitr Infusionsther; 1990; 26():33-6. PubMed ID: 1703866
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with the development of cytomegalovirus infection following solid organ transplantation.
da Cunha-Bang C; Sørensen SS; Iversen M; Sengeløv H; Hillingsø JG; Rasmussen A; Mortensen SA; Fox ZV; Kirkby NS; Christiansen CB; Lundgren JD
Scand J Infect Dis; 2011 May; 43(5):360-5. PubMed ID: 21306196
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.
Peterson PK; Balfour HH; Marker SC; Fryd DS; Howard RJ; Simmons RL
Medicine (Baltimore); 1980 Jul; 59(4):283-300. PubMed ID: 6248718
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus infection in heart transplantation: A single center experience.
Echenique IA; Angarone MP; Rich JD; Anderson AS; Stosor V
Transpl Infect Dis; 2018 Aug; 20(4):e12896. PubMed ID: 29602266
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of cytomegalovirus infection in heart transplant recipients.
Rice PS; Kudesia G; Price C; Smith GH
J Clin Pathol; 1992 Jul; 45(7):636-7. PubMed ID: 1325481
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood products.
Rubie H; Attal M; Campardou AM; Gayet-Mengelle C; Payen C; Sanguignol F; Calot JP; Charlet JP; Robert A; Huguet F
Bone Marrow Transplant; 1993 Mar; 11(3):209-14. PubMed ID: 8385522
[TBL] [Abstract][Full Text] [Related]
17. Incidence of cytomegalovirus disease in cyclosporine-treated renal transplant recipients based on donor/recipient pretransplant immunity.
Weir MR; Irwin BC; Maters AW; Genemans G; Shen SY; Charache P; Williams GM
Transplantation; 1987 Feb; 43(2):187-93. PubMed ID: 3027930
[TBL] [Abstract][Full Text] [Related]
18. Infections due to herpesviruses in cardiac transplant recipients: role of the donor heart and immunosuppressive therapy.
Preiksaitis JK; Rosno S; Grumet C; Merigan TC
J Infect Dis; 1983 Jun; 147(6):974-81. PubMed ID: 6304206
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus infection in living-donor and cadaveric lung transplantations.
Ohata K; Chen-Yoshikawa TF; Takahashi K; Aoyama A; Motoyama H; Hijiya K; Hamaji M; Menju T; Sato T; Sonobe M; Takakura S; Date H
Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):710-715. PubMed ID: 29049752
[TBL] [Abstract][Full Text] [Related]
20. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression.
Hadley S; Samore MH; Lewis WD; Jenkins RL; Karchmer AW; Hammer SM
Transplantation; 1995 Mar; 59(6):851-9. PubMed ID: 7535482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
